Now I have all the information needed. Let me write the consolidated review.

---

## Summary

This paper introduces Constrained Mass Transport (CMT), a variational framework for sampling from unnormalized densities (Boltzmann distributions) by constructing intermediate distributions under joint constraints on KL divergence (trust-region) and entropy decay between successive steps. The authors derive closed-form optimal intermediate densities under these constraints (Propositions 2.1–2.3, Theorem 2.4), instantiate the framework with normalizing flows, and evaluate on four molecular systems including the newly introduced ELIL tetrapeptide (d=219). The paper demonstrates strong empirical performance on EUBO and ESS across all systems, with a thorough ablation study validating the necessity of both constraints.

## Strengths

1. **Clean theoretical derivation of constrained annealing paths.** Propositions 2.1–2.3 provide closed-form optimal intermediate densities under trust-region, entropy, and combined constraints. Theorem 2.4 explicitly connects these constrained optimization problems to annealing paths (geometric, tempered, geometric-tempered). This is a principled foundation that goes beyond heuristic schedule design.

2. **Strong and consistent empirical results across the majority of metrics and systems.** CMT achieves the best EUBO on all four systems and the best ESS on all four systems among energy-based methods. On alanine hexapeptide (d=180), CMT achieves 29.63% ESS versus 18.22% for TA-BG (the best baseline) — a substantial improvement — and on the largest system (ELIL tetrapeptide, d=219), CMT achieves 26.06% ESS versus 13.75% for TA-BG.

3. **Thorough ablation study validating the combined constraint design.** Figures 2 and 3 convincingly demonstrate that omitting either the trust-region or entropy constraint leads to mode collapse or unstable training, whereas the combined geometric-tempered path avoids both. The entropy plots (Figure 2a) and successive ESS plots (Figure 2b) provide direct evidence for the design rationale.

4. **Introduction of a new challenging benchmark (ELIL tetrapeptide, d=219).** As the largest molecular system studied to date under the energy-only variational setting, this provides a more difficult testbed for the community.

5. **Negligible computational overhead of the dual optimization.** The Lagrangian multiplier optimization accounts for only ~0.01% of training time on alanine dipeptide (Section 3), demonstrating that the framework remains practical.

## Weaknesses

### Major

- **Overstated claim of "consistently surpassing" across all systems and metrics.** The main results section (line 246) states: *"Across all systems and metrics, our method outperforms the baselines"* — but this is contradicted by Table 1 on the ELIL tetrapeptide. On Ramachandran TV distance, TA-BG achieves **0.0254 ± 0.0013** while CMT achieves **0.0313 ± 0.0003** (bold removed from CMT, bold assigned to TA-BG for this metric in Table 1). The error bars do not overlap, and ELIL is the largest, most challenging system. While the paper caveats that TA-BG only had 2 successful runs on ELIL (vs. 4 for CMT), the categorical "across all systems and metrics" claim is factually incorrect as written. The abstract claims "consistently surpasses" with emphasis on ESS and mode collapse, which is better supported — but the main text's unqualified statement needs correction.

### Minor

- **The per-step form of the combined-constraint path is geometric, raising a question about whether the entropy constraint adds structural novelty beyond a tighter effective trust-region bound.** From Proposition 2.1 (trust-region only): q_{i+1} ∝ q_i^{1/(1+λ)} p^{1/(1+λ)}. From Proposition 2.3 (combined): q_{i+1} ∝ q_i^{1/(1+λ+η)} p^{1/(1+λ+η)}. Both are geometric paths with different effective exponents. However, Theorem 2.4 shows the combined path has two independent parameters (α, β) vs. one (β) for the trust-region-only case, and the ablation (Figures 2–3) provides empirical evidence that the combined method behaves differently and yields better results. The paper would benefit from a more explicit analytical or toy example demonstrating a qualitative difference, but the current empirical evidence is sufficient to support the approach. This is a presentation/clarity issue rather than a flaw in the method.

- **Forward KL "TARGET EVALS" comparison is potentially misleading.** In Table 1, Forward KL uses 4.2×10⁹ target evaluations for tetrapeptide/hexapeptide/ELIL, far more than the energy-based methods (1×10⁸ to 8×10⁸). The caption states "forward KL is trained from samples rather than from energy," but the column labeled "TARGET EVALS" gives the impression of a direct comparison. Since Forward KL relies on pre-computed MD samples rather than energy calls for training, the cost structure is fundamentally different. The paper should clarify in the table what these evaluations represent for Forward KL (presumably evaluation-time energy calls) or place Forward KL in a separate section.

- **TA-BG on ELIL has only 2 successful runs,** as noted in the footnote. This weakens the statistical comparison on the one metric where TA-BG appears to outperform CMT (Ram TV), since the standard error from 2 runs is unreliable. The authors should acknowledge this asymmetry more prominently when discussing the Ram TV result.

### Trivial

- None.

## Nice-to-Haves

- A controlled experiment matching the effective schedule of the trust-region-only variant to the combined variant would strengthen the argument that the entropy constraint provides benefit beyond schedule tuning.
- Reporting wall-clock time or runtime comparisons in addition to target evaluations would help practical adoption.
- A brief sensitivity discussion for the hyperparameters ε_tr and ε_ent would help practitioners.

## Removed Points

These points from the input reviews are flagged to be removed; treat them with caution.

- *"Mass teleportation mitigation claim lacks theoretical proof."* — The paper explicitly frames this as an empirical observation supported by Figure 1 and Table 1 (Ram TV / EUBO results showing better mode coverage). The claim is "mitigates," not "provably eliminates," which is appropriate for an empirical paper.
- *"ESS reliability tension"* — The paper warns that ESS is less reliable for detecting mode collapse (Section 5.1) and uses EUBO and Ram TV as complementary metrics. This is standard practice; there is no contradiction.
- *"Entropy constraint solution is independent of q_i"* (Proposition 2.2) — The paper acknowledges this limitation and explains that combining with the trust-region constraint resolves it (Section 2). The criticism restates a property the authors already flag and address.
- *"Missing related work"* — Removed per format rules.
- *"Formatting/style nitpicks"* — Removed per format rules.
- *"Reproducibility concerns about undisclosed hyperparameters"* — Reproducibility statement and code link are provided.

## Novel Insights

None beyond the paper's own contributions.

## Suggestions

1. **Temper the overclaiming.** Modify the sentence in Section 5.2 (line 246) from *"Across all systems and metrics, our method outperforms the baselines"* to a more precise claim acknowledging that CMT achieves the best EUBO and ESS on all systems, and the best Ram TV on 3 of 4 systems (with TA-BG achieving better Ram TV on ELIL, though from only 2 runs). The abstract's focus on ESS and mode collapse is already reasonable.

2. **Clarify the Forward KL "TARGET EVALS" column.** Either separate Forward KL into a different row group with a different column label, or add a detailed footnote explaining that these evaluations are for evaluation only (not training) since Forward KL is trained on MD samples.

3. **Add a brief discussion** (even 2 sentences) on why the per-step geometric path from the combined constraint is structurally different from a tighter trust-region-only schedule, referencing the two-parameter path characterization from Theorem 2.4.

## Score and Decision

### Calibration Anchors

**Round 1 (Bracketing):**
- EWFM (avg 2.50, sim 0.74) — Weak paper rejected for limited novelty and scalability concerns. CMT is substantially stronger in theory, experiments, and system sizes.
- Practicality of Boltzmann Neural Samplers (avg 3.00, sim 0.73) — Rejected for weak experiments. CMT is much stronger.
- RegFlow (avg 6.67, sim 0.74) — Accepted (Poster). Proposes regression-based NF training for BGs. Comparable scope. CMT has more novel theory but RegFlow has no overclaiming issue. **CMT is slightly weaker than RegFlow due to the overclaim issue.**
- Constrained Generative Optimization (avg 4.00, sim 0.73) — Different application area, weaker.
- La-Proteina (avg 8.00, sim 0.65) — Different domain (protein generation), not directly comparable.

**Round 2 (Narrowing):**
- Data-to-Energy Stochastic Dynamics (avg 5.00, sim 0.71) — Accepted (Poster). Limited to synthetic datasets. CMT has stronger evaluation. **CMT is clearly better.**
- Enhancing Diffusion-Based Sampling w/ CVs (avg 6.50, sim 0.71) — Accepted (Poster). Strong molecular benchmarks. Different methodological approach. **CMT is of comparable quality.**
- From Predictors to Samplers (avg 5.50, sim 0.71) — Different domain.
- Physics vs Distributions Flow Matching (avg 5.50, sim 0.71) — Different domain.

**Initial bracket (Round 1): 4–7.** Narrowing (Round 2) places CMT between Data-to-Energy SD (5.00) and RegFlow (6.67). CMT's theoretical contribution is stronger than Data-to-Energy SD, but the overclaiming issue (Ram TV on ELIL) prevents it from reaching RegFlow's level. The paper is most comparable to the Enhancing Diffusion-Based Sampling paper (6.50) — both have strong empirical evaluation with a clean methodological contribution and a meaningful weakness. CMT has a cleaner theoretical framework but has a more notable overclaiming issue. Final score: 6.0.

MY FINAL SCORE: <score>6.0</score>
MY FINAL DECISION: <decision>Accept</decision>